Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-08-16 16:07 |
Second Quarter and First Half 2023 Financial Results
|
English | 8.8 MB | ||
| 2023-08-16 16:07 |
Second Quarter and First Half 2023 Financial Results
|
English | 36.2 KB | ||
| 2023-08-09 16:01 |
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial …
|
English | 181.1 KB | ||
| 2023-08-09 16:01 |
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial …
|
English | 36.2 KB | ||
| 2023-07-14 12:23 |
Immediate Report of Meeting to be held on August 29, 2023, proxy statement
|
English | 449.5 KB | ||
| 2023-07-14 12:23 |
Immediate Report of Meeting to be held on August 29, 2023, proxy statement
|
English | 175.0 KB | ||
| 2023-07-14 12:23 |
Immediate Report of Meeting to be held on August 29, 2023, proxy statement
|
English | 90.9 KB | ||
| 2023-07-14 01:07 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON August 29…
|
English | 449.5 KB | ||
| 2023-07-14 01:07 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON August 29…
|
English | 36.0 KB | ||
| 2023-07-12 16:18 |
Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB®…
|
English | 228.0 KB | ||
| 2023-07-12 16:18 |
Kamada Announces Kedrion Exercised its Option for Two-Year Extension of KEDRAB®…
|
English | 36.2 KB | ||
| 2023-05-25 10:28 |
Share purchase agreememnt with FIMI Opportunity Funds -FORM 6K
|
English | 446.3 KB | ||
| 2023-05-25 10:28 |
Share purchase agreememnt with FIMI Opportunity Funds -FORM 6K
|
English | 36.0 KB | ||
| 2023-05-24 16:18 |
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue …
|
English | 6.5 MB | ||
| 2023-05-24 16:18 |
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue …
|
English | 36.1 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
